S&P 500   2,997.24 (+1.05%)
DOW   27,024.70 (+0.89%)
QQQ   193.36 (+1.19%)
AAPL   235.73 (-0.06%)
FB   189.36 (+3.31%)
MSFT   141.53 (+1.42%)
GOOGL   1,242.50 (+2.03%)
AMZN   1,759.16 (+1.31%)
CGC   20.03 (+6.20%)
NVDA   198.78 (+6.57%)
MU   46.40 (+3.43%)
GE   8.86 (+1.61%)
TSLA   258.23 (+0.49%)
T   37.90 (+1.15%)
F   9.09 (+3.06%)
NFLX   284.72 (-0.28%)
BAC   29.87 (+2.51%)
GILD   65.66 (+1.77%)
DIS   129.95 (+0.19%)
S&P 500   2,997.24 (+1.05%)
DOW   27,024.70 (+0.89%)
QQQ   193.36 (+1.19%)
AAPL   235.73 (-0.06%)
FB   189.36 (+3.31%)
MSFT   141.53 (+1.42%)
GOOGL   1,242.50 (+2.03%)
AMZN   1,759.16 (+1.31%)
CGC   20.03 (+6.20%)
NVDA   198.78 (+6.57%)
MU   46.40 (+3.43%)
GE   8.86 (+1.61%)
TSLA   258.23 (+0.49%)
T   37.90 (+1.15%)
F   9.09 (+3.06%)
NFLX   284.72 (-0.28%)
BAC   29.87 (+2.51%)
GILD   65.66 (+1.77%)
DIS   129.95 (+0.19%)
Log in

Express Scripts Stock Price, News & Analysis (NASDAQ:ESRX)

Notice: This company has been marked as potentially delisted and may not be actively trading.
$92.33
0.00 (0.00 %)
(As of 10/15/2019 12:30 PM ET)
Today's Range
$92.33
Now: $92.33
$92.33
50-Day Range
$92.33
MA: $92.33
$92.33
52-Week Range
$66.93
Now: $92.33
$101.73
VolumeN/A
Average Volume6.64 million shs
Market Capitalization$52.06 billion
P/E Ratio13.00
Dividend YieldN/A
Beta0.88
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. Read More…

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryHealth Care Services
SectorMedical
Current SymbolNASDAQ:ESRX
CUSIP30219G10
Phone314-996-0900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$100.06 billion
Cash Flow$10.49 per share
Book Value$32.00 per share

Profitability

Net Income$4.52 billion

Miscellaneous

EmployeesN/A
Market Cap$52.06 billion
Next Earnings DateN/A
OptionableOptionable

Receive ESRX News and Ratings via Email

Sign-up to receive the latest news and ratings for ESRX and its competitors with MarketBeat's FREE daily newsletter.


Express Scripts (NASDAQ:ESRX) Frequently Asked Questions

What is Express Scripts' stock symbol?

Express Scripts trades on the NASDAQ under the ticker symbol "ESRX."

How will Express Scripts' stock buyback program work?

Express Scripts announced that its board has initiated a share repurchase program on Wednesday, December 20th 2017, which authorizes the company to repurchase 45,000,000 shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Stock repurchase programs are often an indication that the company's leadership believes its shares are undervalued.

How were Express Scripts' earnings last quarter?

Express Scripts Holding Co (NASDAQ:ESRX) released its earnings results on Wednesday, October, 31st. The company reported $2.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.42 by $0.01. The company had revenue of $25.56 billion for the quarter, compared to analyst estimates of $25.11 billion. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The business's revenue was up 3.6% compared to the same quarter last year. During the same period in the previous year, the business earned $2.51 EPS. View Express Scripts' Earnings History.

What price target have analysts set for ESRX?

7 brokers have issued 12 month price targets for Express Scripts' stock. Their forecasts range from $88.00 to $101.00. On average, they expect Express Scripts' stock price to reach $96.00 in the next year. This suggests a possible upside of 4.0% from the stock's current price. View Analyst Price Targets for Express Scripts.

What is the consensus analysts' recommendation for Express Scripts?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Express Scripts in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Express Scripts.

Has Express Scripts been receiving favorable news coverage?

News coverage about ESRX stock has been trending somewhat negative on Tuesday, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Express Scripts earned a news impact score of -1.1 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Express Scripts.

Who are some of Express Scripts' key competitors?

What other stocks do shareholders of Express Scripts own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Express Scripts investors own include Gilead Sciences (GILD), Intel (INTC), General Electric (GE), Cisco Systems (CSCO), Walt Disney (DIS), Boeing (BA), Bank of America (BAC), Starbucks (SBUX), CVS Health (CVS) and Celgene (CELG).

Who are Express Scripts' key executives?

Express Scripts' management team includes the folowing people:
  • Mr. Timothy C. Wentworth, CEO, Pres & Director (Age 58)
  • Mr. James M. Havel, Exec. VP & CFO (Age 63)
  • Mr. David A. Queller, Sr. VP of Sales & Account Management (Age 49)
  • Ms. Christine Houston, Exec. VP of Strategic Integrations (Age 55)
  • Mr. Everett Neville, Exec. VP of Strategy, Supply Chain & Specialty (Age 53)

What is Express Scripts' stock price today?

One share of ESRX stock can currently be purchased for approximately $92.33.

How big of a company is Express Scripts?

Express Scripts has a market capitalization of $52.06 billion and generates $100.06 billion in revenue each year. The company earns $4.52 billion in net income (profit) each year or $7.10 on an earnings per share basis. View Additional Information About Express Scripts.

What is Express Scripts' official website?

The official website for Express Scripts is http://www.express-scripts.com/.

How can I contact Express Scripts?

Express Scripts' mailing address is ONE EXPRESS WAY, SAINT LOUIS MO, 63121. The company can be reached via phone at 314-996-0900 or via email at [email protected]


MarketBeat Community Rating for Express Scripts (NASDAQ ESRX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  974 (Vote Outperform)
Underperform Votes:  720 (Vote Underperform)
Total Votes:  1,694
MarketBeat's community ratings are surveys of what our community members think about Express Scripts and other stocks. Vote "Outperform" if you believe ESRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ESRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel